Healthcare mergers and acquisitions remained strong in the third quarter of 2026, with maintaining access to care amid rising costs emerging as a central driver of deal activity. Kaufman Hall, a healthcare financial advisory firm, expects 2026 to be the most active year for health provider M&A since the start of the pandemic.
“Organizations are increasingly pursuing partnerships that support future strategic priorities rather than scale alone,” said Courtney Midanek, managing director and M&A practice co-leader at Kaufman Hall, in a press release. “Health systems across the industry are expanding networks, pursuing complementary capabilities and investing in” areas designed to strengthen long-term resilience.
Background: A Sector Under Financial Pressure
Hospitals and health systems have faced sustained financial strain since the pandemic. Labor shortages, elevated supply and drug costs, and uneven patient volumes have squeezed margins across the industry. Many smaller and rural providers have struggled most, prompting consolidation as a survival strategy.
Deal activity had already accelerated in prior years as organizations sought scale in purchasing, payer negotiations and administrative operations. The current wave, however, reflects a shift in priorities. Observers note that buyers are increasingly seeking specific clinical capabilities, digital infrastructure and geographic reach rather than simply larger footprints.
Strategic Partnerships Over Scale
Midanek’s comments point to a change in deal rationale. Rather than pursuing mega-mergers, many organizations are forming affiliations, joint ventures and targeted acquisitions that fill service gaps. Behavioral health, ambulatory care, home-based services and outpatient surgery have drawn significant interest from buyers looking to shift care to lower-cost settings.
Advocates of this approach argue that focused partnerships can preserve local decision-making while delivering operational benefits. Critics, however, have long cautioned that consolidation can reduce competition and raise prices for patients, a concern that regulators continue to monitor closely.
Access to Care at the Center of the Debate
Maintaining access to care has become a defining theme in how deals are presented to the public. Health systems frequently cite commitments to keep rural hospitals open, preserve emergency services and maintain charity care as part of their transaction announcements. Whether these pledges translate into durable outcomes remains a subject of ongoing scrutiny from state attorneys general and policy analysts.
Federal and state regulators have signaled increased attention to healthcare transactions, particularly those involving private equity sponsors or cross-market consolidation. Review processes have grown more involved, and some proposed deals have been delayed or abandoned after regulatory objections.
Industry Implications
For patients, the trend could bring expanded service lines and integrated care coordination, but it may also affect pricing and provider choice in some regions. For employers and insurers, larger systems can strengthen negotiating leverage, which may influence premium and reimbursement dynamics. For smaller independent practices, the environment presents both pressure to join larger networks and opportunities to find well-matched partners.
Investors and executives will watch whether 2026’s deal momentum translates into measurable improvements in margins and quality metrics. The sustainability of current activity will depend heavily on interest rates, reimbursement policy and the outcomes of pending regulatory reviews.
What to Watch Next
Attention now turns to fourth-quarter deal volume, particularly whether Kaufman Hall’s projection of record-level activity holds. Analysts will also track how regulators respond to transactions framed around access commitments, and whether new federal or state guidance reshapes how health system mergers are evaluated. The coming months will reveal whether today’s partnership-driven strategy delivers the stability that organizations are seeking.
Frequently Asked Questions
Why are healthcare providers pursuing so many mergers and acquisitions in 2026?
Hospitals and health systems have faced prolonged financial strain since the pandemic, including labor shortages, high supply and drug costs, and uneven patient volumes. Consolidation has become a survival strategy, especially for smaller and rural providers, and buyers are now seeking specific clinical capabilities and geographic reach rather than just larger size.
How do strategic partnerships differ from traditional mergers in this context?
Rather than pursuing large mergers that combine entire organizations, many providers now form affiliations, joint ventures and targeted acquisitions that fill particular service gaps. This approach can help preserve local decision-making while still delivering operational benefits, and it often focuses on areas such as behavioral health, outpatient surgery or home-based services.
Do healthcare mergers actually raise prices for patients?
Critics have long argued that consolidation can reduce competition and lead to higher prices, which is why regulators monitor these deals closely. The actual effect varies by region and transaction, and the article notes that its long-term impact on pricing and provider choice remains a subject of debate rather than settled fact.
What do access-to-care pledges in healthcare deals really mean?
Health systems often announce commitments to keep rural hospitals open, preserve emergency services and maintain charity care when they complete transactions. Whether these promises produce lasting results is still under scrutiny from state attorneys general and policy analysts, so readers should look for enforceable terms and follow-up reporting rather than assuming the pledges will be met.
Why are regulators paying closer attention to certain healthcare transactions?
Federal and state regulators have increased oversight, particularly for deals involving private equity sponsors or consolidation across multiple markets. Reviews have become more involved, and some proposed deals have been delayed or abandoned after regulatory objections, which adds uncertainty to transaction timelines.
How could these deals affect employers and insurers?
Larger health systems can strengthen their negotiating leverage in payer contracts, which may influence premium levels and reimbursement rates. Employers and insurers may therefore face different cost dynamics in regions where provider consolidation has increased, making it worthwhile to watch how local market concentration evolves.